Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
Quarterly results
|
|
Insys Therapeutics, Inc. (INSY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/06/2019 |
4
| Housley Andrece (CFO) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 3,992 shares
@ $0
Granted 31,008 options to buy
@ $4.3, valued at
$133.3k
|
|
| 06/06/2019 |
3
| Housley Andrece (CFO) has filed a Form 3 on Insys Therapeutics, Inc. |
| 06/05/2019 |
4
| Long Andrew G (CEO) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 12,475 shares
@ $0
Granted 72,674 options to buy
@ $4.3, valued at
$312.5k
|
|
| 04/23/2019 |
4
| BOHLEN ELIZABETH (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 8,083 shares
@ $0
Granted 20,935 options to buy
@ $6.36, valued at
$133.1k
|
|
| 04/23/2019 |
4
| Mahboob Vaseem (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 8,083 shares
@ $0
Granted 20,935 options to buy
@ $6.36, valued at
$133.1k
|
|
| 04/23/2019 |
4
| Nance Mark E (Chief Legal Officer & Gen Cnsl) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 10,000 shares
@ $0
Granted 70,000 options to buy
@ $3.81, valued at
$266.7k
|
|
| 04/23/2019 |
4
| Vanhove Geertrui (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Granted 8,083 shares
@ $0
Granted 24,000 options to buy
@ $5.96, valued at
$143k
Granted 20,935 options to buy
@ $6.36, valued at
$133.1k
|
|
| 04/23/2019 |
3
| Vanhove Geertrui (Director) has filed a Form 3 on Insys Therapeutics, Inc. |
| 04/23/2019 |
4
| Motahari Saeed (President & CEO) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 16,000 shares
@ $0
Granted 59,206 shares
@ $0
Granted 64,000 options to buy
@ $8.06, valued at
$515.8k
Granted 282,152 options to buy
@ $3.81, valued at
$1.1M
|
|
| 04/23/2019 |
4
| Long Andrew G (CFO) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 10,600 shares
@ $0
Granted 29,000 shares
@ $0
Granted 42,400 options to buy
@ $8.06, valued at
$341.7k
Granted 173,000 options to buy
@ $3.81, valued at
$659.1k
|
|
| 04/23/2019 |
4
| MEYER STEVEN J (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Granted 8,083 shares
@ $0
Granted 16,000 options to buy
@ $8.06, valued at
$129k
Granted 20,935 options to buy
@ $6.36, valued at
$133.1k
|
|
| 04/23/2019 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Granted 8,083 shares
@ $0
Granted 16,000 options to buy
@ $8.06, valued at
$129k
Granted 20,935 options to buy
@ $6.36, valued at
$133.1k
|
|
| 04/23/2019 |
4
| Vishnoi Rohit (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Granted 8,083 shares
@ $0
Granted 16,000 options to buy
@ $8.06, valued at
$129k
Granted 20,935 options to buy
@ $6.36, valued at
$133.1k
|
|
| 04/19/2019 |
4
| Vishnoi Rohit (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Granted 8,083 shares
@ $0
Granted 16,000 options to buy
@ $8.06, valued at
$129k
Granted 20,935 options to buy
@ $6.36, valued at
$133.1k
|
|
| 04/19/2019 |
4
| Long Andrew G (CFO) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 10,600 shares
@ $0
Granted 29,000 shares
@ $0
Granted 42,400 options to buy
@ $8.06, valued at
$341.7k
Granted 173,000 options to buy
@ $3.81, valued at
$659.1k
|
|
| 04/19/2019 |
4
| Motahari Saeed (President & CEO) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 16,000 shares
@ $0
Granted 59,206 shares
@ $0
Granted 64,000 options to buy
@ $8.06, valued at
$515.8k
Granted 282,152 options to buy
@ $3.81, valued at
$1.1M
|
|
| 04/19/2019 |
4
| Nance Mark E (Chief Legal Officer & Gen Cnsl) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 10,000 shares
@ $0
Granted 70,000 options to buy
@ $3.81, valued at
$266.7k
|
|
| 04/19/2019 |
4
| Mahboob Vaseem (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 8,083 shares
@ $0
Granted 20,935 options to buy
@ $6.36, valued at
$133.1k
|
|
| 04/19/2019 |
4
| BOHLEN ELIZABETH (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 8,083 shares
@ $0
Granted 20,935 options to buy
@ $6.36, valued at
$133.1k
|
|
| 04/19/2019 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Granted 8,083 shares
@ $0
Granted 16,000 options to buy
@ $8.06, valued at
$129k
Granted 20,935 options to buy
@ $6.36, valued at
$133.1k
|
|
| 04/19/2019 |
4
| MEYER STEVEN J (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Granted 8,083 shares
@ $0
Granted 16,000 options to buy
@ $8.06, valued at
$129k
Granted 20,935 options to buy
@ $6.36, valued at
$133.1k
|
|
| 04/19/2019 |
4
| Vanhove Geertrui (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Granted 8,083 shares
@ $0
Granted 24,000 options to buy
@ $5.96, valued at
$143k
Granted 20,935 options to buy
@ $6.36, valued at
$133.1k
|
|
| 04/19/2019 |
3
| Vanhove Geertrui (Director) has filed a Form 3 on Insys Therapeutics, Inc. |
| 10/12/2018 |
4
| Nance Mark E (Chief Legal Officer & Gen Cnsl) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 15,000 shares
@ $0
Granted 100,000 options to buy
@ $8.61, valued at
$861k
|
|
| 10/12/2018 |
3
| Nance Mark E (Chief Legal Officer & Gen Cnsl) has filed a Form 3 on Insys Therapeutics, Inc. |
| 08/09/2018 |
4
| BOHLEN ELIZABETH (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Granted 24,000 options to buy
@ $6.65, valued at
$159.6k
|
|
| 08/09/2018 |
3
| BOHLEN ELIZABETH (Director) has filed a Form 3 on Insys Therapeutics, Inc. |
| 08/07/2018 |
4
| Long Andrew G (CFO) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Disposed/sold 5,000 restricted stock units
@ $0 |
|
| 05/14/2018 |
4
| Tambi Brian (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Exercised 33,654 shares
@ $0.61, valued at
$20.5k
Exercised 68,850 shares
@ $1.62, valued at
$111.5k
Exercised 60,000 shares
@ $3.63, valued at
$217.8k
Sold 166,504 shares
@ $6.41, valued at
$1.1M
Disposed/sold 4,000 restricted stock units
@ $0
Exercised 33,654 options to buy
@ $0
Exercised 68,850 options to buy
@ $0
Exercised 60,000 options to buy
@ $0 |
|
| 05/10/2018 |
4
| Vishnoi Rohit (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Disposed/sold 6,000 restricted stock units
@ $0 |
|
| 05/10/2018 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Disposed/sold 4,000 restricted stock units
@ $0 |
|
| 05/10/2018 |
4
| MEYER STEVEN J (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Disposed/sold 4,000 restricted stock units
@ $0 |
|
| 04/17/2018 |
4
| Motahari Saeed (President & CEO) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 11,000 shares
@ $0
Disposed/sold 11,000 restricted stock units
@ $0 |
|
| 03/08/2018 |
3
| Insys Therapeutics, Inc. Voting Trust (10% Owner) has filed a Form 3 on Insys Therapeutics, Inc. |
|
|
|